Protecht’s Integrations Hub connects Protecht with the applications, data sources, and systems your organisation already uses. The result? GRC that fits naturally into day-to-day work. Find out more: bit.ly/3QFugDI #RiskManagement #GRC #Compliance #RegTech #SaaS

Join Michael Howell and Stewart Dowrick tomorrow (Tuesday 16) for Risk Governance in Healthcare: What Boards Need From Leaders. Register now to watch the discussion: bit.ly/43xjXVh #HealthcareRisk #ClinicalGovernance #RiskManagement #Governance #Protecht

G2’s Spring 2026 reports are out, and the results reflect how customers are evaluating GRC platforms today. Protecht was recognised across 93 reports, earning 14 badges including multiple Leader positions: bit.ly/4bF4shC #RiskManagement #GRC #Compliance #RegTech #SaaS

ProTecht 2026 brought together 30 leading technology partners who showcased Adani business–specific innovations, designed to build safer and smarter workplaces at scale. With over 2,500 attendees in the presence of Gautam Adani, Jeet Adani, Pranav Adani, Sagar Adani and Srushti Adani, the expo reflected a shared vision for a future-ready India, powered by technology.

ProTecht 2026, the Adani Safety Technology Exposition, was inaugurated by Jeet Adani, Sagar Adani and Srushti Adani. The two-day exposition showcases customised safety technology solutions aligned to Adani’s business operations, alongside technical sessions and employee engagement initiatives that strengthen a culture of safety as a foundation for building a future-ready India.

100 HEMATOLOGY SCORES — why validation matters 🧪📊 (Ultra-brief exam-oriented one-liners 🧬 MALIGNANT HEMATOLOGY (1–45) 1️⃣ ELN 2022 AML ⚠️ – genetic risk → therapy intent 2️⃣ ELN AML response ✅ – defines CR/CRi/MLFS 3️⃣ IPSS (MDS) 🧬 – baseline risk, outdated cytogenetics 4️⃣ IPSS-R 🔬 – refined cytopenias & cytogenetics 5️⃣ IPSS-M 🧠 – adds molecular precision 6️⃣ WPSS 📈 – WHO subtype transfusions 7️⃣ IWG-MDS response 📊 – response standardization 8️⃣ AML MRD framework 🔍 – depth of remission 9️⃣ TRM-AML ☠️ – early mortality prediction 🔟 ALFA AML score 🎯 – intermediate-risk refinement 1️⃣1️⃣ CLL-IPI 🧪 – survival risk stratification 1️⃣2️⃣ iwCLL treatment criteria ⚖️ – when to treat 1️⃣3️⃣ iwCLL response ✅ – response definitions 1️⃣4️⃣ CIRS 🏥 – comorbidity/fitness 1️⃣5️⃣ ECOG-PS 🚶 – functional status 1️⃣6️⃣ IPI 💥 – aggressive lymphoma prognosis 1️⃣7️⃣ aaIPI 🎚️ – age-adjusted IPI 1️⃣8️⃣ R-IPI 🔁 – rituximab era refinement 1️⃣9️⃣ NCCN-IPI 🎯 – modern risk discrimination 2️⃣0️⃣ CNS-IPI 🧠 – CNS relapse risk 2️⃣1️⃣ FLIPI 🌿 – FL survival risk 2️⃣2️⃣ FLIPI-2 📈 – progression risk 2️⃣3️⃣ PRIMA-PI 🔎 – low vs high FL risk 2️⃣4️⃣ POD24 ⏱️ – early progression = poor prognosis 2️⃣5️⃣ IPS (HL) 🎻 – classic HL prognosis 2️⃣6️⃣ Hasenclever 🎼 – HL risk factors 2️⃣7️⃣ PIT (PTCL) 🧩 – PTCL outcome 2️⃣8️⃣ mPIT 🔧 – improved PTCL accuracy 2️⃣9️⃣ PINK 🐼 – NK/T survival risk 3️⃣0️⃣ PINK-E 🧪 – EBV-adjusted NK/T risk 3️⃣1️⃣ MIPI 🧬 – mantle cell prognosis 3️⃣2️⃣ MIPI-b 🧫 – adds biology (Ki-67) 3️⃣3️⃣ Lugano 📏 – lymphoma response rules 3️⃣4️⃣ Deauville 📸 – PET metabolic response 3️⃣5️⃣ RECIL 📐 – tumor size–based response 3️⃣6️⃣ ISS (MM) 🧲 – tumor burden 3️⃣7️⃣ R-ISS 🔥 – cytogenetics LDH 3️⃣8️⃣ R2-ISS 🧠 – further MM refinement 3️⃣9️⃣ Mayo 20/2/20 ⏳ – SMM progression risk 4️⃣0️⃣ IMWG response ✅ – MM response language 4️⃣1️⃣ IMWG frailty 👴 – treatment tolerance 4️⃣2️⃣ R-MCI 🧾 – MM comorbidity survival 4️⃣3️⃣ MCI 🧩 – transplant fitness 4️⃣4️⃣ MM PET negativity 📸 – deep response marker 4️⃣5️⃣ IMWG MRD 🔍 – minimal disease burden ⸻ 🌋 MPN / CML / MF (46–65) 4️⃣6️⃣ IPSET-Thrombosis 🚦 – ET vascular risk 4️⃣7️⃣ Revised IPSET 🚦 – modern ET risk 4️⃣8️⃣ DIPSS 🌋 – PMF survival 4️⃣9️⃣ DIPSS-Plus ➕ – transfusion & cytogenetics 5️⃣0️⃣ MIPSS70 🧬 – genetics-based PMF risk 5️⃣1️⃣ MIPSS70 v2 🧠 – updated molecular model 5️⃣2️⃣ GIPSS 🧬 – genetics only 5️⃣3️⃣ MYSEC-PM 🔄 – secondary MF risk 5️⃣4️⃣ ELTS 🎯 – best OS predictor in CML 5️⃣5️⃣ Sokal 📜 – historical CML risk 5️⃣6️⃣ Hasford/Euro 🇪🇺 – CML survival 5️⃣7️⃣ EUTOS 🧾 – CML response risk 5️⃣8️⃣ EUTOS-LTS ⏳ – long-term survival 5️⃣9️⃣ MPN-SAF 📋 – symptom burden 6️⃣0️⃣ WHO fibrosis grade 🧫 – marrow progression 6️⃣1️⃣ IWG-MRT response 📊 – MF treatment response 6️⃣2️⃣ Blast-phase MPN models ⚠️ – leukemic risk 6️⃣3️⃣ PV risk stratification 🩸 – thrombotic risk 6️⃣4️⃣ ET survival scores ⏱️ – long-term risk 6️⃣5️⃣ ELN cytoreduction criteria 📐 – treatment threshold ⸻ 🌱 TRANSPLANT / CELL THERAPY (66–82) 6️⃣6️⃣ HCT-CI 🫀 – NRM prediction 6️⃣7️⃣ EBMT score 🌍 – allo-SCT outcome 6️⃣8️⃣ DRI 🎯 – disease biology impact 6️⃣9️⃣ Refined DRI 🔁 – better discrimination 7️⃣0️⃣ CIBMTR models 🧾 – registry-based risk 7️⃣1️⃣ Karnofsky PS 🧍 – transplant fitness 7️⃣2️⃣ Frailty indices 👴 – toxicity risk 7️⃣3️⃣ Glucksberg aGVHD 🔥 – severity grading 7️⃣4️⃣ IBMTR aGVHD 🧪 – alternative grading 7️⃣5️⃣ NIH cGVHD 🧴 – chronic severity 7️⃣6️⃣ MAGIC GI-GVHD 🍽️ – objective staging 7️⃣7️⃣ EASIX 🩸 – endothelial injury 7️⃣8️⃣ VOD/SOS criteria 🚨 – hepatic toxicity 7️⃣9️⃣ ASTCT CRS 🌡️ – cytokine toxicity 8️⃣0️⃣ ASTCT ICANS 🧠 – neurotoxicity grading 8️⃣1️⃣ CTCAE v5 📄 – adverse events 8️⃣2️⃣ NRM models ⚠️ – transplant mortality ⸻ 🩸 COAGULATION / TMA / VTE (83–100) 8️⃣3️⃣ PLASMIC 🧠 – rapid iTTP detection 8️⃣4️⃣ French TTP score 🇫🇷 – ADAMTS13 prediction 8️⃣5️⃣ ISTH DIC 📄 – overt DIC diagnosis 8️⃣6️⃣ JAAM DIC 🏥 – sepsis-focused DIC 8️⃣7️⃣ SIC score 🦠 – early sepsis coagulopathy 8️⃣8️⃣ 4T score 4️⃣ – HIT probability 8️⃣9️⃣ HEP score 🧾 – HIT alternative 9️⃣0️⃣ Khorana 🎗️ – cancer VTE risk 9️⃣1️⃣ PROTECHT 💊 – chemo-associated VTE

IO am going to make an epixc tweet. I think that liek ,Everyone sohould be lolveyl . ANd nobodyh should hate eachouther. Because like, we are all peo;le on the planet,. ANd the planet is like, precipousl, ANd we shopuld protecht the neviroement,. BUT LIKE not extremely, thas bad

What’s In My Gym Bag - PROTECHT GRIPS / Must Have for Smartwatches youtu.be/MpDlmN_bcPo?si=eZIu… via @YouTube

PROTECHT HİM!

The Protecht team are live and ready to go at #RiskEurope in London. Come and find us over the next two days: we're at booths #136 and 86, so between that and our five presentation opportunities, you can't miss us! #GRC #RiskManagement #Compliance #AIGovernance #RegTech

HES GOING TO PROTECHT.

First iOS app in review for launch. Rep timer for lifters for better time under tension. Think Seconds timer for runners, but for lifters and their reps. Fun side project to go with PROTECHT and help create the gear and software for the tech-first future of lifters.

4/ 📉 RAMs performance (c-statistic): CAT Score: 0.65 PROTECHT: 0.58 EHR-CAT: 0.55 CONKO: 0.54 Khorana: 0.53 COMPASS-CAT: 0.50 ❌ 🎯 Best was still only modest. #mmsm #MedEd #myeloma #MedTwitter #USMIRC @USMIRCNEWS @OncoAlert #سرطان_الدم #المايلوما #Oncology #hematology

3/ 🧪 The study: 806 cancer patients starting modern systemic therapy (🧬33.6% got ICIs). 6 RAMs tested: Khorana, PROTECHT, CONKO, COMPASS-CAT, CAT Score, EHR-CAT. 📆 Follow-up: 6 months 📈 VTE incidence: 11.2% #mmsm #MedEd #myeloma #MedTwitter #USMIRC @USMIRCNEWS @OncoAlert #سرطان_الدم #المايلوما #Oncology #hematology

Sponsored by protecht

Read our latest CPS 230 blog for practical guidance on how Protecht connects the dots between risk, continuity, and outsourcing in one platform, helping you to meet the standard with confidence: bit.ly/3HlNkSx #cps230 #apra #operationalrisk #operationalresilience

Appreciate you! trying to protecht your time as a brand owner SaaS slinger puppy dad

My Tasks in Protecht ERM streamlines task management by consolidating all assigned actions in one place, allowing you to complete tasks efficiently without navigating back and forth between dashboards or emails. Watch the video now to find out more:

Yo - I honestly can't say enough good things about Simple bundles. I use it for protecht and find it really clean both setup inventory wise.

LAST CHANCE TO REGISTER: In this special webinar, Protecht’s thought leaders David Tattam and Michael Howell break down the key insights from David’s book Risk Appetite For Dummies, Protecht Special Edition, and show you how to apply them in practice: bit.ly/3GjMrsY